ViiV registers two HIV studies: DDI trial for VH4011499 and NIAID-led PALACE trialNov 16Weekly roundup, 2 itemscabotegravirGilead Sciences
Novo Nordisk registers four Phase 3 AMBITION trials for zenagamtide in type 2 diabetesNov 12Weekly roundup, 5 itemsNovo Nordisk A/SsemaglutideUpdated
Amgen gets Amjevita label update; registers Phase 3 MariTide trial against semaglutideNov 6Weekly roundup, 5 itemsadalimumab-attoAmgenUpdated
Bayer completes Phase 1 drug interaction study of sevabertinib with metforminOct 27Weekly roundup, 2 itemsBayerfinerenone
Merck's KEYNOTE-522 posts results in triple negative breast cancer; new PAH study starts in IndiaOct 22Weekly roundup, 5 itemsMerck & Co., Inc.pembrolizumabUpdated
Lilly posts Phase 3 results for orforglipron and lebrikizumab; discloses abemaciclib trial haltOct 16Weekly roundup, 7 itemsabemaciclibBayerUpdated
Amgen registers new Phase 3 maridebart cafraglutide vs. semaglutide trial in type 2 diabetesOct 8Weekly roundup, 3 itemsAMG-513AmgenUpdated
Lilly posts Phase 3 orforglipron results; registers new MDD trial and five other updatesOct 2Weekly roundup, 10 itemsbaricitinibbrenipatideUpdated
Lilly's orforglipron posts Phase 3 diabetes results; six new trials registeredSep 18Weekly roundup, 7 itemsEli Lillyorforglipron
Novo Nordisk posts PIONEER TEENS results; registers three new trials for obesity and injectionsAug 21Weekly roundup, 4 itemsNNC0721-8060Novo Nordisk A/S
Novo Nordisk posts results for two semaglutide trials, opens new NNC0487-0111 studyAug 14Weekly roundup, 3 itemsNNC0487-0111Novo Nordisk A/S
Amneal clears five FDA supplements: REMS update on buprenorphine/naloxone leads weekAug 14Weekly roundup, 5 itemsAmneal Pharmaceuticals, LLCbuprenorphine
FDA clears five ANDA supplements for Teva and Actavis Labs generics, mostly labeling updatesAug 14Weekly roundup, 5 itemsTeva Pharmaceutical Industries Ltd
Sun Pharma logs eleven FDA labeling supplements and two REMS updates in one weekAug 14Weekly roundup, 11 itemsisotretinoinSun Pharmaceutical Industries
FDA clears four Zydus labeling supplements for generic diabetes and diuretic tabletsAug 11Weekly roundup, 4 itemsZydus Lifesciences
CSPC Ouyi gets FDA labeling approvals for metformin hydrochloride tablets and ER tabletsAug 11Weekly roundup, 2 itemsCSPC Pharmaceutical Groupmetformin
Mylan wins FDA approval for labeling supplement on metformin ER tabletsAug 11Regulatory decisionmetforminViatris Inc.
Glenmark posts two ANDA labeling supplement approvals for metformin, riluzoleAug 11Weekly roundup, 2 itemsGlenmark Pharmaceuticalsmetformin
Bayer registers Phase 1 sevabertinib-metformin interaction study in healthy adultsAug 7Weekly roundup, 2 itemsBayermetformin
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsJul 31Weekly roundup, 6 itemsabelacimabDDY391
Sun Pharma gets ANDA nod for sugammadex; two metformin labeling supplements approvedJul 29Weekly roundup, 3 itemsmetforminsugammadex
Amneal adds metformin labeling approval alongside bosentan updatesJul 23Weekly roundup, 2 itemsAmneal Pharmaceuticals, LLCbosentan
Zydus wins two new generic approvals, edaravone and fluvoxamine ER, plus metformin label updatesJul 23Weekly roundup, 3 itemsedaravonefluvoxamine
Zydus Pharms gets FDA approvals for selenious acid ANDA and two glyburide/metformin label updatesJun 30Weekly roundup, 2 itemsglyburidemetformin